Kath Watson

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

William G Dixon, Kimme L Hyrich, Kath Watson et al. · Annals of the Rheumatic Diseases · 2009 · 710 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

James Galloway, Kimme L Hyrich, Louise Mercer et al. · Lara D. Veeken · 2010 · 671 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register

William G Dixon, Kath Watson, Mark Lunt et al. · Arthritis & Rheumatism · 2007 · 561 citations · Full text

Medicine, Immunology, Internal Medicine +17

Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study

Kimme L Hyrich, Mark Lunt, Kath Watson et al. · Arthritis & Rheumatism · 2006 · 403 citations

Medicine, Pharmacology, Pharmacotherapy +13

Low back pain in schoolchildren: occurrence and characteristics

Kath Watson, A C Papageorgiou, Gareth T. Jones et al. · Pain · 2002 · 346 citations

Medicine, Child Health, Pediatrics +17